Canadian Cannabis Tilray Stock Earns Relative Strength Rating Upgrade

On Tuesday, Tilray (TLRY) cleared an important performance benchmark, with its Relative Strength (RS) Rating jumping into the 80-plus percentile with an upgrade to 81, a rise from 69 the day before.

The Canadian pot producer recently completed merger with Aphria, making Tilray stock a bigger player in the marijuana industry. For more industry news on pot stocks, check out “Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?


When you’re researching the best stocks to buy and watch, be sure to pay attention to relative price strength.

This exclusive rating from Investor’s Business Daily tracks share price action with a 1 (worst) to 99 (best) score. The grade shows how a stock’s price performance over the trailing 52 weeks holds up against all the other stocks in our database.

History shows that the market’s biggest winners often have an 80 or better RS Rating as they launch their biggest runs.

See How IBD Helps You Make More Money In Stocks

Since hitting a 52-week high of 67 on Feb. 10, Tilray stock has pulled back in a distribution along with most growth stocks. It’s currently out of buy range after clearing a 12.25 buy point in a first-stage cup without handle in January.  See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line. Check out “Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks.”


The Canadian marijuana company posted negative growth for both the top and bottom lines last quarter. Most companies in this sector has yet to post profits, but may see potential future growth as regulation eases in the U.S.

The company holds the No. 11 rank among its peers in the Consumer Products-Specialty industry group. Central Garden & Pet (CENT) and Energizer (ENR) are also among the group’s highest-rated stocks. Other Cannabis stocks in the industry include Canopy Growth (CGC) and Cronos Group (CRON).


MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button